{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:36:33Z","timestamp":1759991793172},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12891-015-0823-8","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T12:56:44Z","timestamp":1448542604000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression"],"prefix":"10.1186","volume":"16","author":[{"given":"Katelin R.","family":"Haynes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsu-Wen","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Kneissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor T.","family":"Glant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gethin P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"823_CR1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","volume":"58","author":"D Heijde Van der","year":"2008","unstructured":"Van der Heijde D, Landew\u00e9 R, Einstein S, Ory P, Vosse D, Ni L, et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum. 2008;58:1324\u201331.","journal-title":"Arthritis Rheum"},{"key":"823_CR2","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","volume":"58","author":"D Heijde Van der","year":"2008","unstructured":"Van der Heijde D, Landew\u00e9 R, Baraliakos X, Houben H, van Tubergen A, Williamson P, et al. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum. 2008;58:3063\u201370.","journal-title":"Arthritis Rheum"},{"key":"823_CR3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2012-202698","volume":"73","author":"X Baraliakos","year":"2014","unstructured":"Baraliakos X, Haibel H, Listing J, Sieper J, Braun J. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8\u00a0years in patients with ankylosing spondylitis. Ann Rheum Dis. 2014;73:710\u20135.","journal-title":"Ann Rheum Dis"},{"key":"823_CR4","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","volume":"11","author":"D Heijde Van der","year":"2009","unstructured":"Van der Heijde D, Salonen D, Weissman BN, Landew\u00e9 R, Maksymowych WP, Kupper H, et al. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2\u00a0years. Arthritis Res Ther. 2009;11:R127.","journal-title":"Arthritis Res Ther"},{"key":"823_CR5","first-page":"CD010952","volume":"7","author":"FP Kroon","year":"2015","unstructured":"Kroon FP, van der Burg LR, Ramiro S, Landew\u00e9 RB, Buchbinder R, Falzon L, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev. 2015;7:CD010952.","journal-title":"Cochrane Database Syst Rev"},{"key":"823_CR6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"A Wanders","year":"2005","unstructured":"Wanders A, Van Der HD, Landew\u00e9 R, B\u00e9hier J-M, Calin A, Olivieri I, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52:1756\u201365.","journal-title":"Arthritis Rheum"},{"key":"823_CR7","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2012-203148","volume":"72","author":"D Poddubnyy","year":"2013","unstructured":"Poddubnyy D, Haibel H, Listing J, M\u00e4rker-Hermann E, Zeidler H, Braun J, et al. Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC). Ann Rheum Dis. 2013;72:1430\u20132.","journal-title":"Ann Rheum Dis"},{"key":"823_CR8","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/annrheumdis-2012-201370","volume":"71","author":"F Kroon","year":"2012","unstructured":"Kroon F, Landew\u00e9 R, Dougados M, van der Heijde D. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis. 2012;71:1623\u20139.","journal-title":"Ann Rheum Dis"},{"key":"823_CR9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","volume":"65","author":"N Haroon","year":"2013","unstructured":"Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, et al. The impact of tumor necrosis factor \u03b1 inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2013;65:2645\u201354.","journal-title":"Arthritis Rheum"},{"key":"823_CR10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013;19:179\u201392.","journal-title":"Nat Med"},{"key":"823_CR11","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","volume":"22","author":"DG Winkler","year":"2003","unstructured":"Winkler DG, Sutherland MK, Geoghegan JC, Yu C, Hayes T, Skonier JE, et al. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003;22:6267\u201376.","journal-title":"EMBO J"},{"issue":"2","key":"823_CR12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jbmr.2351","volume":"30","author":"R Recker","year":"2014","unstructured":"Recker R, Benson C, Matsumoto T, Bolognese M, Robins D, Alam J, et al. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J Bone Miner Res. 2014;30(2):216\u201324.","journal-title":"J Bone Miner Res"},{"key":"823_CR13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, et al. Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med. 2014;370:412\u201320.","journal-title":"N Engl J Med"},{"key":"823_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.1780300211","volume":"30","author":"TT Glant","year":"1987","unstructured":"Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB\/c mice. Clinical features and histopathology. Arthritis Rheum. 1987;30:201\u201312.","journal-title":"Arthritis Rheum"},{"key":"823_CR15","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1186\/ar4096","volume":"14","author":"KR Haynes","year":"2012","unstructured":"Haynes KR, Pettit AR, Duan R, Tseng H-W, Glant TT, Brown MA, et al. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res Ther. 2012;14:R253.","journal-title":"Arthritis Res Ther"},{"key":"823_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/art.1780300310","volume":"30","author":"K Mikecz","year":"1987","unstructured":"Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB\/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum. 1987;30:306\u201318.","journal-title":"Arthritis Rheum"},{"key":"823_CR17","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/oby.2012.101","volume":"20","author":"M Diaz","year":"2012","unstructured":"Diaz M, Martel N, Fitzsimmons RL, Eriksson NA, Cowin GJ, Thomas GP, et al. Ski overexpression in skeletal muscle modulates genetic programs that control susceptibility to diet-induced obesity and insulin signaling. Obesity (Silver Spring). 2012;20:2157\u201367.","journal-title":"Obesity (Silver Spring)"},{"key":"823_CR18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.2004.029710","volume":"64","author":"T B\u00e1rdos","year":"2005","unstructured":"B\u00e1rdos T, Szab\u00f3 Z, Czipri M, Vermes C, Tunyogi-Csap\u00f3 M, Urban RM, et al. A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann Rheum Dis. 2005;64:981\u20137.","journal-title":"Ann Rheum Dis"},{"key":"823_CR19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4049\/jimmunol.181.2.1232","volume":"181","author":"MK Chang","year":"2008","unstructured":"Chang MK, Raggatt L-J, Alexander KA, Kuliwaba JS, Fazzalari NL, Schroder K, et al. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo. J Immunol. 2008;181:1232\u201344.","journal-title":"J Immunol"},{"key":"823_CR20","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/jcp.22902","volume":"227","author":"LF Castro De","year":"2012","unstructured":"De Castro LF, Lozano D, Portal-N\u00fa\u00f1ez S, Maycas M, De la Fuente M, Caeiro JR, et al. Comparison of the skeletal effects induced by daily administration of PTHrP (1\u201336) and PTHrP (107\u2013139) to ovariectomized mice. J Cell Physiol. 2012;227:1752\u201360.","journal-title":"J Cell Physiol"},{"key":"823_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2474-14-99","volume":"14","author":"M Korkosz","year":"2013","unstructured":"Korkosz M, G\u0105sowski J, Leszczy\u0144ski P, Pawlak-Bu\u015b K, Jeka S, Kucharska E, et al. High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage. BMC Musculoskelet Disord. 2013;14:99.","journal-title":"BMC Musculoskelet Disord"},{"key":"823_CR22","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","volume":"60","author":"H Appel","year":"2009","unstructured":"Appel H, Ruiz-Heiland G, Listing J, Zwerina J, Herrmann M, Mueller R, et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2009;60:3257\u201362.","journal-title":"Arthritis Rheum"},{"key":"823_CR23","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jbmr.345","volume":"26","author":"GJ Atkins","year":"2011","unstructured":"Atkins GJ, Rowe PS, Lim HP, Welldon KJ, Ormsby R, Wijenayaka AR, et al. Sclerostin is a locally acting regulator of late-osteoblast\/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanism. J Bone Miner Res. 2011;26:1425\u201336.","journal-title":"J Bone Miner Res"},{"key":"823_CR24","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1136\/ard.2010.132852","volume":"69","author":"GR Heiland","year":"2010","unstructured":"Heiland GR, Zwerina K, Baum W, Kireva T, Distler JH, Grisanti M, et al. Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis. 2010;69:2152\u20139.","journal-title":"Ann Rheum Dis"},{"key":"823_CR25","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1359\/jbmr.090305","volume":"24","author":"C Vincent","year":"2009","unstructured":"Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res. 2009;24:1434\u201349.","journal-title":"J Bone Miner Res"},{"key":"823_CR26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3727\/096504011X13021877989874","volume":"19","author":"AA El-Mabhouh","year":"2011","unstructured":"El-Mabhouh AA, Nation PN, Abele JT, Riauka T, Postema E, McEwan AJB, et al. A conjugate of gemcitabine with bisphosphonate (Gem\/BP) shows potential as a targeted bone-specific therapeutic agent in an animal model of human breast cancer bone metastases. Oncol Res. 2011;19:287\u201395.","journal-title":"Oncol Res"},{"key":"823_CR27","first-page":"164","volume":"8","author":"JL Mill\u00e1n","year":"2012","unstructured":"Mill\u00e1n JL, Plotkin H. Hypophosphatasia - pathophysiology and treatment. Actual osteol. 2012;8:164\u201382.","journal-title":"Actual osteol"},{"key":"823_CR28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1359\/jbmr.071213","volume":"23","author":"JL Mill\u00e1n","year":"2008","unstructured":"Mill\u00e1n JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, et al. Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res. 2008;23:777\u201387.","journal-title":"J Bone Miner Res"},{"key":"823_CR29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012;366:904\u201313.","journal-title":"N Engl J Med"},{"key":"823_CR30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/annrheumdis-2012-202544","volume":"72","author":"C Beyer","year":"2013","unstructured":"Beyer C, Reichert H, Akan H, Mallano T, Schramm A, Dees C, et al. Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Ann Rheum Dis. 2013;72:1255\u20138.","journal-title":"Ann Rheum Dis"},{"key":"823_CR31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/art.21740","volume":"54","author":"TM Tran","year":"2006","unstructured":"Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, et al. Additional human \u03b22-microglobulin curbs HLA\u2013B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA\u2013B27\u2013transgenic rats. Arthritis Rheum. 2006;54:1317\u201327.","journal-title":"Arthritis Rheum"},{"key":"823_CR32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/path.4519","volume":"236","author":"F Gen\u00eat","year":"2015","unstructured":"Gen\u00eat F, Kulina I, Vaquette C, Torossian F, Millard S, Pettit AR, et al. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage-mediated inflammation in muscle. J Pathol. 2015;236:229\u201340.","journal-title":"J Pathol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-015-0823-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T18:23:51Z","timestamp":1718216631000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2474\/16\/368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1186\/s12891-015-0823-8","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,26]]},"article-number":"368"}}